Skip to main content

Advertisement

Log in

Can intra-operative intraperitoneal free cancer cell detection techniques identify patients at higher recurrence risk following curative colorectal cancer resection: a meta-analysis

  • Gastrointestinal Oncology
  • Original Papers
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Accurate staging of colorectal cancer is important for predicting prognosis and guiding treatment. This study uses meta-analysis to investigate if the pre- or post-resection detection of intraperitoneal free cancer cells can predict recurrence in patients undergoing curative colorectal cancer surgery.

Methods

A literature search was performed on all studies between January 1990 and July 2007 comparing the detection of intraperitoneal free cancer cells either pre- or post-resection with prognosis in colorectal cancer. The following prognostic outcomes were meta-analyzed: overall recurrence rate and local recurrence rate. A random-effect model was used and heterogeneity was assessed.

Results

Nine studies reporting on a total of 1182 subjects matched the selection criteria. Free cancer cells were detected prior to tumor resection in 125/822 (15.2%) of patients and following resection in 64/533 (12%) of patients. Preresection, the absence of tumor cells was associated with a lower overall recurrence (25.2%) compared to the presence of tumor cells [46.4%, odds ratio (OR) = 0.41, confidence interval (CI) 0.19–0.88]; as well as a significantly lower local recurrence (12.2% versus 21.1%, OR = 0.42, CI 0.21–0.82). Postresection, the absence of tumor cells also resulted in significantly lower overall recurrence (17.3%) when compared to the presence of tumor cells (52.6%, OR = 0.07, CI 0.03–0.18).

Conclusions

The detection of intraperitoneal free cancer cells is associated with higher recurrence and poorer prognosis. Use of these techniques can identify patients at higher recurrence risk. This could be particularly valuable in stage II disease to identify patients who may benefit from adjuvant chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

FIG. 1.
FIG. 2.
FIG. 3.

Similar content being viewed by others

References

  1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74–108

    Article  PubMed  Google Scholar 

  2. Dukes CE. The classification of cancer of the rectum. J Pathol Bacteriol 1932;35:323–32

    Article  Google Scholar 

  3. Astler VB, Coller FA. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 1954;139:846–52

    Article  PubMed  CAS  Google Scholar 

  4. Hutter RV. At last–worldwide agreement on the staging of cancer. Arch Surg 1987;122:1235–9

    PubMed  CAS  Google Scholar 

  5. Jass JR, O’Brien MJ, Riddell RH, et al. Recommendations for the reporting of surgically resected specimens of colorectal carcinoma. Hum Pathol 2007

  6. Merkel S, Mansmann U, Papadopoulos T, et al. The prognostic inhomogeneity of colorectal carcinomas Stage III: a proposal for subdivision of Stage III. Cancer 2001;92:2754–9

    Article  PubMed  CAS  Google Scholar 

  7. Greene FL, Stewart AK, Norton HJ. A new TNM staging strategy for node-positive (stage III) colon cancer: an analysis of 50,042 patients. Ann Surg 2002;236:416–21

    Article  PubMed  Google Scholar 

  8. Liefers GJ, Cleton-Jansen AM, van de Velde CJ, et al. Micrometastases and survival in stage II colorectal cancer. N Engl J Med 1998;339:223–8

    Article  PubMed  CAS  Google Scholar 

  9. Nelson H, Petrelli N, Carlin A, et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 2001;93:583–96

    Article  PubMed  CAS  Google Scholar 

  10. Michelassi F, Vannucci L, Ayala JJ, et al. Local recurrence after curative resection of colorectal adenocarcinoma. Surgery 1990;108:787–92

    PubMed  CAS  Google Scholar 

  11. Hansen E, Wolff N, Knuechel R, et al. Tumor cells in blood shed from the surgical field. Arch Surg 1995;130:387–93

    PubMed  CAS  Google Scholar 

  12. Feezor RJ, Copeland EM, III, Hochwald SN. Significance of micrometastases in colorectal cancer. Ann Surg Oncol 2002;9:944–53

    Article  PubMed  Google Scholar 

  13. Carmignani CP, Sugarbaker TA, Bromley CM, et al. Intraperitoneal cancer dissemination: mechanisms of the patterns of spread. Cancer Metastasis Rev 2003;22:465–72

    Article  PubMed  Google Scholar 

  14. Umpleby HC, Fermor B, Symes MO, et al. Viability of exfoliated colorectal carcinoma cells. Br J Surg 1984;71:659–63

    Article  PubMed  CAS  Google Scholar 

  15. Fermor B, Umpleby HC, Lever JV, et al. Proliferative and metastatic potential of exfoliated colorectal cancer cells. J Natl Cancer Inst 1986;76:347–9

    PubMed  CAS  Google Scholar 

  16. Skipper D, Cooper AJ, Marston JE, et al. Exfoliated cells and in vitro growth in colorectal cancer. Br J Surg 1987;74:1049–52

    Article  PubMed  CAS  Google Scholar 

  17. Uras C, Altinkaya E, Yardimci H, et al. Peritoneal cytology in the determination of free tumour cells within the abdomen in colon cancer. Surg Oncol 1996;5:259–63

    Article  PubMed  CAS  Google Scholar 

  18. Leather AJ, Gallegos NC, Kocjan G, et al. Detection and enumeration of circulating tumour cells in colorectal cancer. Br J Surg 1993;80:777–80

    Article  PubMed  CAS  Google Scholar 

  19. Aoki S, Takagi Y, Hayakawa M, et al. Detection of peritoneal micrometastases by reverse transcriptase-polymerase chain reaction targeting carcinoembryonic antigen and cytokeratin 20 in colon cancer patients. J Exp Clin Cancer Res 2002;21:555–62

    PubMed  CAS  Google Scholar 

  20. Ojima H, Sasaki S, Fujisawa T, et al. Utility of serosal stamp cytology as an indicator for high-risk peritoneal metastasis in colorectal cancer surgery. Hepatogastroenterology 2003;50:87–90

    PubMed  Google Scholar 

  21. Leather AJ, Kocjan G, Savage F, et al. Detection of free malignant cells in the peritoneal cavity before and after resection of colorectal cancer. Dis Colon Rectum 1994;37:814–9

    Article  PubMed  CAS  Google Scholar 

  22. Bentrem D, Wilton A, Mazumdar M, et al. The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection. Ann Surg Oncol 2005;12:347–53

    Article  PubMed  Google Scholar 

  23. Ribeiro U, Jr., Safatle-Ribeiro AV, Zilberstein B, et al. Does the intraoperative peritoneal lavage cytology add prognostic information in patients with potentially curative gastric resection? J Gastrointest Surg 2006;10:170–6, discussion

    Article  PubMed  Google Scholar 

  24. Rosenberg R, Nekarda H, Bauer P, et al. Free peritoneal tumour cells are an independent prognostic factor in curatively resected stage IB gastric carcinoma. Br J Surg 2006;93:325–31

    Article  PubMed  CAS  Google Scholar 

  25. Benedet JL, Bender H, Jones H, III, et al. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 2000;70:209–62

    Article  PubMed  CAS  Google Scholar 

  26. Kienle P, Koch M. Minimal residual disease in gastrointestinal cancer. Semin Surg Oncol 2001;20:282–93

    Article  PubMed  CAS  Google Scholar 

  27. Clarke. Cochrane reviewer’s handbook 4.1.3. Oxford, UK: The Cochrane Library, 2001

  28. Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Onkologie 2000;23:597–602

    Article  PubMed  Google Scholar 

  29. Egger M, Davey SG, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629–34

    PubMed  CAS  Google Scholar 

  30. Egger M, Smith GD. Misleading meta-analysis. BMJ 1995;311:753–4

    PubMed  CAS  Google Scholar 

  31. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177–88

    Article  PubMed  CAS  Google Scholar 

  32. Gozalan U, Yasti AC, Yuksek YN, et al. Peritoneal cytology in colorectal cancer: incidence and prognostic value. Am J Surg 2007;193:672–5

    Article  PubMed  Google Scholar 

  33. Kanellos I, Zacharakis E, Kanellos D, et al. Prognostic significance of CEA levels and positive cytology in peritoneal washings in patients with colorectal cancer. Colorectal Dis 2006;8:436–40

    Article  PubMed  CAS  Google Scholar 

  34. Lloyd JM, McIver CM, Stephenson SA, et al. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells. Clin Cancer Res 2006;12:417–23

    Article  PubMed  CAS  Google Scholar 

  35. Baskaranathan S, Philips J, McCredden P, et al. Free colorectal cancer cells on the peritoneal surface: correlation with pathologic variables and survival. Dis Colon Rectum 2004;47:2076–9

    Article  PubMed  Google Scholar 

  36. Kanellos I, Demetriades H, Zintzaras E, et al. Incidence and prognostic value of positive peritoneal cytology in colorectal cancer. Dis Colon Rectum 2003;46:535–9

    Article  PubMed  CAS  Google Scholar 

  37. Yamamoto S, Akasu T, Fujita S, et al. Long-term prognostic value of conventional peritoneal cytology after curative resection for colorectal carcinoma. Jpn J Clin Oncol 2003;33:33–7

    Article  PubMed  Google Scholar 

  38. Bosch B, Guller U, Schnider A, et al. Perioperative detection of disseminated tumour cells is an independent prognostic factor in patients with colorectal cancer. Br J Surg 2003;90:882–8

    Article  PubMed  CAS  Google Scholar 

  39. Guller U, Zajac P, Schnider A, et al. Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer. Ann Surg 2002;236:768–75

    Article  PubMed  Google Scholar 

  40. Vogel I, Francksen H, Soeth E, et al. The carcinoembryonic antigen and its prognostic impact on immunocytologically detected intraperitoneal colorectal cancer cells. Am J Surg 2001;181:188–93

    Article  PubMed  CAS  Google Scholar 

  41. Vogel P, Ruschoff J, Kummel S, et al. Prognostic value of microscopic peritoneal dissemination: comparison between colon and gastric cancer. Dis Colon Rectum 2000;43:92–100

    Article  PubMed  CAS  Google Scholar 

  42. Wind P, Norklinger B, Roger V, et al. Long-term prognostic value of positive peritoneal washing in colon cancer. Scand J Gastroenterol 1999;34:606–10

    Article  PubMed  CAS  Google Scholar 

  43. Hase K, Ueno H, Kuranaga N, et al. Intraperitoneal exfoliated cancer cells in patients with colorectal cancer. Dis Colon Rectum 1998;41:1134–40

    Article  PubMed  CAS  Google Scholar 

  44. Schott A, Vogel I, Krueger U, et al. Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker. Ann Surg 1998;227:372–9

    Article  PubMed  CAS  Google Scholar 

  45. Broll R, Lembcke K, Stock C, et al. Tumor cell dissemination in bone marrow and peritoneal cavity. An immunocytochemical study of patients with stomach or colorectal carcinoma. Langenbecks Arch Chir 1996;381:51–8

    Article  PubMed  CAS  Google Scholar 

  46. Ambrose NS, MacDonald F, Young J, et al. Monoclonal antibody and cytological detection of free malignant cells in the peritoneal cavity during resection of colorectal cancer–can monoclonal antibodies do better? Eur J Surg Oncol 1989;15:99–102

    PubMed  CAS  Google Scholar 

  47. Vogel P, Ruschoff J, Kummel S, et al. Immunocytology improves prognostic impact of peritoneal tumour cell detection compared to conventional cytology in gastric cancer. Eur J Surg Oncol 1999;25:515–9

    Article  PubMed  CAS  Google Scholar 

  48. To EM, Chan WY, Chow C, et al. Gastric cancer cell detection in peritoneal washing: cytology versus RT-PCR for CEA transcripts. Diagn Mol Pathol 2003;12:88–95

    Article  PubMed  CAS  Google Scholar 

  49. Lindemann F, Schlimok G, Dirschedl P, et al. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 1992;340:685–9

    Article  PubMed  CAS  Google Scholar 

  50. Eisenberg B, Decosse JJ, Harford F, et al. Carcinoma of the colon and rectum: the natural history reviewed in 1704 patients. Cancer 1982;49:1131–4

    Article  PubMed  CAS  Google Scholar 

  51. Douillard JY, Cunningham D, Roth AD, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 2000;355:1041–7

    Article  PubMed  CAS  Google Scholar 

  52. Benson AB, III, Choti MA, Cohen AM, et al. NCCN Practice Guidelines for Colorectal Cancer. Oncology 2000;14:203–12

    PubMed  Google Scholar 

  53. Figueredo A, Charette ML, Maroun J, et al. Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care’s gastrointestinal cancer disease site group. J Clin Oncol 2004;22:3395–407

    Article  PubMed  Google Scholar 

  54. Benson AB, III, Schrag D, Somerfield MR, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 2004;22:3408–19

    Article  PubMed  Google Scholar 

  55. Yan TD, Black D, Savady R, et al. Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol 2006;24:4011–9

    Article  PubMed  Google Scholar 

  56. Brodsky JT, Cohen AM. Peritoneal seeding following potentially curative resection of colonic carcinoma: implications for adjuvant therapy. Dis Colon Rectum 1991;34:723–7

    Article  PubMed  CAS  Google Scholar 

  57. Sugarbaker PH. Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 1999;43(Suppl):S15–S25

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sushil Rekhraj MSc, MRCS.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rekhraj, S., Aziz, O., Prabhudesai, S. et al. Can intra-operative intraperitoneal free cancer cell detection techniques identify patients at higher recurrence risk following curative colorectal cancer resection: a meta-analysis. Ann Surg Oncol 15, 60–68 (2008). https://doi.org/10.1245/s10434-007-9591-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-007-9591-5

Keywords

Navigation